{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:16:19Z","timestamp":1765541779998,"version":"3.48.0"},"reference-count":22,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    The widespread misuse of antibiotics over the past several decades has been regarded as the contributing factor in the development of resistance toward them. Extended spectrum \u03b2-lactamases (ESBLs) are enzymes produced by certain bacteria that can make them resistant to certain antibiotics. Early detection of ESBL strains and judicious use of antibiotics and proper implementation of infection control strategies are essential to prevent the spread of this threat in the community. The study aimed at appraising the prevalence, risk factors and antimicrobial susceptibility pattern of ESBL-producing microorganisms.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A prospective observational study was carried out in a tertiary care referral hospital located in Malappuram district of Kerala among inpatients with infection by ESBL-producing bacteria in order to estimate the prevalence, risk factors and their antibiotic susceptibility pattern.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Out of the total 1156 patients studied, 118 had confirmed diagnosis on the presence of ESBL-producing microorganisms. Overall, 9.79% of all samples growing\n                    <jats:italic>Enterobacteriaceae<\/jats:italic>\n                    yielded an ESBL producer. Out of the total isolates identified, 66.1% were urinary tract infections, 15.1% were respiratory tract infections, 14.4% were surgical site infections and the remaining constituted blood stream infections. The highest antimicrobial activity against ESBL-producing isolates was observed for meropenem.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    High prevalence of ESBL-producing organisms is evident in the study setting implicating the necessity to report the ESBL production along with the routine sensitivity reports supplemented with control measures which can assist a clinician in prescribing appropriate antibiotics.\n                  <\/jats:p>","DOI":"10.1515\/jbcpp-2015-0020","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T11:22:19Z","timestamp":1453807339000},"page":"155-162","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence, risk factors and antimicrobial susceptibility pattern of extended spectrum \u03b2-lactamase-producing bacteria in a tertiary care hospital"],"prefix":"10.1515","volume":"27","author":[{"given":"Dilip","family":"Chandrasekhar","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Al Shifa College of Pharmacy, Poonthavanam, Kizhattur, P.O. Perinthalmanna, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaffer","family":"Chalilparambil","sequence":"additional","affiliation":[{"name":"Department of General Medicine, KIMS Al Shifa Hospital, Perinthalmanna, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajitha Mukriyan","family":"Kallungal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Al Shifa College of Pharmacy, Poonthavanam, Kizhattur, P.O. Perinthalmanna, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danisha","family":"Pattani","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Al Shifa College of Pharmacy, Poonthavanam, Kizhattur, P.O. Perinthalmanna, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abin","family":"Chandrakumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Al Shifa College of Pharmacy, Poonthavanam, Kizhattur, P.O. Perinthalmanna, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Pokkavayalil","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Al Shifa College of Pharmacy, Poonthavanam, Kizhattur, P.O. Perinthalmanna, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,1,26]]},"reference":[{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_001_w2aab2b8c21b1b7b1ab2ab1Aa","unstructured":"Tripathi KD. Antimicrobial drugs: general considerations. In: Tripathi KD, editor. Essentials of medical pharmacology, 5th ed. New Delhi: Jaypee Publishers, 2003:627\u201340."},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_002_w2aab2b8c21b1b7b1ab2ab2Aa","doi-asserted-by":"crossref","unstructured":"Reghunath D. Emerging antibiotic resistance bacteria with special reference to India. J Biosci 2008;33:593\u2013603.10.1007\/s12038-008-0077-919208984","DOI":"10.1007\/s12038-008-0077-9"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_003_w2aab2b8c21b1b7b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"Komlafe OO. Antibiotic resistance in bacteria-an emerging public health problem. Malawi Med J 2004;15:63\u20137.10.4314\/mmj.v15i2.10780334543627528961","DOI":"10.4314\/mmj.v15i2.10780"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_004_w2aab2b8c21b1b7b1ab2ab4Aa","doi-asserted-by":"crossref","unstructured":"Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS. High prevalence of extended-spectrum \u03b2-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist 2012;5:65\u201373.10.2147\/IDR.S30043334588122570555","DOI":"10.2147\/IDR.S30043"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_005_w2aab2b8c21b1b7b1ab2ab5Aa","unstructured":"Thenmozhi S, Sureshkumar BT. Prevalence of extended spectrum beta-lactamase producing gram-negative bacteria in private hospital, Tiruchengode, Tamilnadu, India. Int J Curr Microbiol App Sci 2013;2:280\u20139."},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_006_w2aab2b8c21b1b7b1ab2ab6Aa","doi-asserted-by":"crossref","unstructured":"Enoch DA, Brown F, Sismey AW, Mlangeni DA, Curran MD, Karas JA, et al. Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a UK district hospital; an observational study. J Hosp Infect 2012;81:270\u20137.10.1016\/j.jhin.2012.05.00622742987","DOI":"10.1016\/j.jhin.2012.05.006"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_007_w2aab2b8c21b1b7b1ab2ab7Aa","doi-asserted-by":"crossref","unstructured":"Schoevaerdts D, Bogaerts P, Grimmelprez A, de Saint-Hubert M, Delaere B, Jamart J, et al. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital. BMC Infect Dis 2011;11:12.10.1186\/1471-2334-11-12302369821226923","DOI":"10.1186\/1471-2334-11-12"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_008_w2aab2b8c21b1b7b1ab2ab8Aa","doi-asserted-by":"crossref","unstructured":"Fennell J, Vellinga A, Hanahoe B, Morris D, Boyle F, Higgins F. Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study. BMC Infect Dis 2012;12:116.10.1186\/1471-2334-12-116346213622587773","DOI":"10.1186\/1471-2334-12-116"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_009_w2aab2b8c21b1b7b1ab2ab9Aa","doi-asserted-by":"crossref","unstructured":"Peralta G, Lamelo M, \u00c1lvarez-Garc\u00eda P, Velasco M, Delgado A, Horcajada JP, et al. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis 2012;12:245.10.1186\/1471-2334-12-245351970123038999","DOI":"10.1186\/1471-2334-12-245"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_010_w2aab2b8c21b1b7b1ab2ac10Aa","doi-asserted-by":"crossref","unstructured":"Sarojamma V, Rmakrishna V. Prevalence of ESBL-producing Klebsiella pneumoniae isolates in tertiary care hospital. ISRN Microbiol 2011;2011:5.10.5402\/2011\/318348365847823724303","DOI":"10.5402\/2011\/318348"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_011_w2aab2b8c21b1b7b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"Rubio-Perez I, Martin-Perez E, Garcia DD, Calvo ML, Barrera EL. Extended-spectrum beta-lactamase-producing bacteria in a tertiary care hospital in Madrid: epidemiology, risk factors and antimicrobial susceptibility patterns. Emerg Health Threats J 2012;5:1\u20136.10.3402\/ehtj.v5i0.11589340074222822411","DOI":"10.3402\/ehtj.v5i0.11589"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_012_w2aab2b8c21b1b7b1ab2ac12Aa","doi-asserted-by":"crossref","unstructured":"Rivard-Yazigi L, Zahar JR, Le Guillou S, Chalouhi C, Lecuyer H, Bureau C, et al. Risk factors associated with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae carriage at admission in an infant cohort at a tertiary teaching hospital in France. Am J Infect Control 2013;41:844\u20135.10.1016\/j.ajic.2012.11.01623465604","DOI":"10.1016\/j.ajic.2012.11.016"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_013_w2aab2b8c21b1b7b1ab2ac13Aa","doi-asserted-by":"crossref","unstructured":"Khan SA, Feroz F, Noor R. Study of extended-spectrum \u03b2-lactamase-producing bacteria from urinary tract infections in Bangladesh. Tzu Chi Med J 2013;25:39\u201342.10.1016\/j.tcmj.2013.01.008","DOI":"10.1016\/j.tcmj.2013.01.008"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_014_w2aab2b8c21b1b7b1ab2ac14Aa","doi-asserted-by":"crossref","unstructured":"Doernberg SB, Winston LG. Risk factors for acquisition of extended-spectrum \u03b2-lactamase-producing Escherichia coli in an urban county hospital. Am J Infect Control 2012;40:123\u20137.10.1016\/j.ajic.2011.04.001","DOI":"10.1016\/j.ajic.2011.04.001"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_015_w2aab2b8c21b1b7b1ab2ac15Aa","doi-asserted-by":"crossref","unstructured":"Lee DS, Lee CB, Lee S-J. Prevalence and risk factors for extended spectrum beta-lactamase-producing uropathogens in patients with urinary tract infection. Korean J Urol 2010;51:492\u20137.10.4111\/kju.2010.51.7.492","DOI":"10.4111\/kju.2010.51.7.492"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_016_w2aab2b8c21b1b7b1ab2ac16Aa","doi-asserted-by":"crossref","unstructured":"Mehrgan H, Rahbar M. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 2008;31:147\u201351.10.1016\/j.ijantimicag.2007.09.008","DOI":"10.1016\/j.ijantimicag.2007.09.008"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_017_w2aab2b8c21b1b7b1ab2ac17Aa","doi-asserted-by":"crossref","unstructured":"Wu UI, Yang CS, Chen WC, Chen YC, Chang SC. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. J Microbiol Immunol Infect 2010;43:310\u20136.10.1016\/S1684-1182(10)60048-5","DOI":"10.1016\/S1684-1182(10)60048-5"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_018_w2aab2b8c21b1b7b1ab2ac18Aa","doi-asserted-by":"crossref","unstructured":"Villegas MV, Blanco MG, Sifuentes-Osornio J, Rossi F. Increasing prevalence of extended-spectrum-beta-lactamase among gram-negative bacilli in Latin America \u2013 2008 update from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Braz J Infect Dis 2011;15:34\u20139.10.1590\/S1413-86702011000100007","DOI":"10.1590\/S1413-86702011000100007"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_019_w2aab2b8c21b1b7b1ab2ac19Aa","doi-asserted-by":"crossref","unstructured":"Nasa P, Juneja D, Singh O, Dang R, Singh A. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome. Eur J Intern Med 2012;23:192\u20135.10.1016\/j.ejim.2011.06.01622284253","DOI":"10.1016\/j.ejim.2011.06.016"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_020_w2aab2b8c21b1b7b1ab2ac20Aa","doi-asserted-by":"crossref","unstructured":"Lonchel CM, Meex C, Gangou\u00e9-Pi\u00e9boji J, Boreux R, Assoumou MC, Melin P, et al. Proportion of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect Dis 2012;12:53.10.1186\/1471-2334-12-53332963722405322","DOI":"10.1186\/1471-2334-12-53"},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_021_w2aab2b8c21b1b7b1ab2ac21Aa","unstructured":"Shanthi M, Sekar U. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. J Assoc Phys India 2010;58(Suppl):41\u20134."},{"key":"2025121209201102943_j_jbcpp-2015-0020_ref_022_w2aab2b8c21b1b7b1ab2ac22Aa","unstructured":"Dalela G. Prevalence of extended-spectrum beta lactamase (ESBL) producers among gram negative bacilli from various clinical isolates in a tertiary care hospital at Jhalawar, Rajasthan, India. J Clin Diagn Res 2012;6:182\u20137."}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2015-0020\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2015-0020\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:11:50Z","timestamp":1765541510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2015-0020\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,26]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,10,24]]},"published-print":{"date-parts":[[2016,3,1]]}},"alternative-id":["10.1515\/jbcpp-2015-0020"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2015-0020","relation":{},"ISSN":["2191-0286","0792-6855"],"issn-type":[{"type":"electronic","value":"2191-0286"},{"type":"print","value":"0792-6855"}],"subject":[],"published":{"date-parts":[[2016,1,26]]}}}